|
Description:
|
|
GPCR tools don’t move the field forward unless researchers can actually use them. This episode breaks down how collaboration turns probes into progress. Summary In the final episode of this series, David Hodson, Johannes Broichhagen, and Maria Majellaro unpack how academic labs and Celtarys Research partnered to scale fluorescent probes, improve assay development, and support gpcr drug discovery. The conversation spans receptor internalization, fluorescence assays, tech transfer realities, and why tool availability—not just invention—drives translational pharmacology research.
Key takeaways Why accessibility defines the real impact of GPCR tools How industry enables scalable assay development Lessons from receptor internalization studies in complex tissues What makes academia–industry collaborations actually work
Read more here: https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/scaling-glp-1-receptor-tools-through-academia–industry-collaboration |